Skip to main content
Clinical Trials/NCT01138540
NCT01138540
Terminated
Phase 3

Prospective, Randomized, Multi-Center Trial of Lateral Trendelenburg Versus Semi-Recumbent Body Position in Mechanically Ventilated Patients For The Prevention of Ventilator-Associated Pneumonia

Policlinico Hospital2 sites in 2 countries800 target enrollmentNovember 2010

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Ventilator Associated Pneumonia
Sponsor
Policlinico Hospital
Enrollment
800
Locations
2
Primary Endpoint
Incidence of ventilator-associated pneumonia
Status
Terminated
Last Updated
8 years ago

Overview

Brief Summary

This study is planned to compare, in patients sedated, intubated and mechanically ventilated, the efficacy and safety of the Lateral Trendelenburg position in comparison to the Semirecumbent Position to prevent incidence of ventilator-associated pneumonia (VAP).

Detailed Description

This study is planned to compare, in patients sedated, intubated or tracheostomized and mechanically ventilated, the efficacy and safety of two body positions in reducing incidence of ventilator-associated pneumonia. The semi-recumbent position prevents gastro-oropharyngeal aspiration of bacteria laden gastric contents and the "gastro-pulmonary" route of colonization. The lateral-Trendelenburg position aims to promote outward drainage of bacteria-laden oropharyngeal secretion, while avoiding bacterial translocation from the oropharynx into the lungs.

Registry
clinicaltrials.gov
Start Date
November 2010
End Date
April 2015
Last Updated
8 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Policlinico Hospital
Responsible Party
Principal Investigator
Principal Investigator

Mauro Panigada, MD

MD

Policlinico Hospital

Eligibility Criteria

Inclusion Criteria

  • Age ≥ 18 years
  • Patients expected to be oro-tracheally intubated for at least 48 hours or longer
  • Enrollment time window within 12 hours following intubation

Exclusion Criteria

  • Current and past participation in an other intervention trial conflicting with the present study
  • Previous endotracheal intubation longer than 12 hours during the previous 30 days
  • Patients with documented bronchiectasis
  • Cystic fibrosis
  • Witnessed pulmonary aspiration either prior or at intubation
  • Patients with increased intracranial pressure, brain edema; or medical conditions that can worsen with increase in intracranial pressure
  • Patients with significant heart failure and activity impairment (Class III-IV of the New York Heart Association (NYHA)
  • Spinal cord injury
  • BMI \> 35, or weight above 300 pound
  • Grade IV Intra-abdominal pressure: IAP \> 25 mmHg or abdominal compartment syndrome , defined as a sustained IAP \> 20 mmHg that is associated with new organ dysfunction / failure

Outcomes

Primary Outcomes

Incidence of ventilator-associated pneumonia

Time Frame: 14 days of mechanical ventilation

incidence of ventilator-associated pneumonia within the first 14 days of intubation, confirmed by quantitative microbiology analysis of either bronchoalveolar lavage (BAL) or mini-BAL fluids or secretions collected through protected specimen brush (PSB)

Secondary Outcomes

  • 28 Days mortality(28 days)
  • Duration of hospital stay(days)
  • Safety of the Semi-Recumbent and Lateral-Trendelenburg position(14 days)
  • Duration of mechanical ventilation(14 days)
  • Duration of intensive care unit stay(days)
  • Use of Sedatives(14 days)
  • Use of Antimicrobials(14 days)
  • ICU mortality(28 days)
  • Hospital mortality(28 days)
  • Assessment of nursing-related issues in the lateral-Trendelenburg position(14 days)

Study Sites (2)

Loading locations...

Similar Trials